20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
The Price And Volume Action In Kintara Therapeutics's Stock Today
Kintara Therapeutics (NASDAQ:KTRA) is currently down 7.64% to a price of $2.46. The stock's volume is currently 77.04 thousand, which is roughly 4.66% of its recent 30-day volume average of 1.66 million.
Why It's Moving
Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Kintara Therapeutics shares are trading lower after the company reported Q2 EPS results down from last year.
Perspective On Recent Price Action
The stock's 50-day moving average was $1.61 at the time this article was published. Over the past fifty-two weeks, the price has risen as high as $3.35 and fallen to a low of $1.03.
If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!